Interdomain interactions in the mineralocorticoid receptor

Molecular and Cellular Endocrinology

Volumn 200, Issue 1-2, 2003, Pages 45-55

  Rogerson, Fraser M ^a   Fuller, Peter J ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Aldosterone; Cortisol; Ligand binding domain; Mineralocorticoid receptor; N terminal domain

Indexed keywords

ALDOSTERONE; GALANIN DERIVATIVE; HYDROCORTISONE; LIGAND; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIMERIZATION; DNA BINDING; DRUG INHIBITION; GENE MUTATION; HYBRIDIZATION; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

ALDOSTERONE; ANIMALS; COS CELLS; DIMERIZATION; HUMANS; HYDROCORTISONE; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, MINERALOCORTICOID; RECOMBINANT FUSION PROTEINS; SPIRONOLACTONE; TRANS-ACTIVATION (GENETICS); TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0037469632     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00413-6     Document Type: Article

References (32)

1. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 237:1987;268-275.
2. Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engström L., Öhman L., Greene G.L., Gustafsson J.-Å., Carlquist M. Molecular basis of agonism and antagonism of the oestrogen receptor. Nature. 389:1997;753-758.
3. Eisen L.P., Harmon J.M. Activation of the rat kidney mineralocorticoid receptor. Endocrinology. 119:1986;1419-1426.
4. Fagart J., Wurtz J.-M., Souque A., Hellal-Levy C., Moras D., Rafestin-Oblin M.-E. Antagonism in the human mineralocorticoid receptor. EMBO J. 17:1998;3317-3325.
5. Fawell S.E., Lees J.A., White R., Parker M.G. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell. 60:1990;953-962.
6. Fuse H., Kitagawa H., Kato S. Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1). Mol. Endocrinol. 14:2000;889-899.
7. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:2000;121-141.
8. Gomez-Sanchez E.P., Venkatamaran M.T., Thwaites D., Fort C. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am. J. Physiol. 258:1990;E649-E653.
9. Govindan M.V., Warriar N. Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor. J. Biol. Chem. 273:1998;24439-24447.
10. He B., Kemppainen J.A., Wilson E.M. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand-binding domain of the androgen receptor. J. Biol. Chem. 275:2000;22986-22994.
11. 2- and COOH-terminal interaction. J. Biol. Chem. 277:2002;25631-25639.
12. Hong H., Kohli K., Garabedian M.J., Stallcup M.R. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid and vitamin D receptors. Mol. Cell. Biol. 17:1997;2735-2744.
13. Kitagawa H., Yanigasawa J., Fuse H., Ogawa S., Yogiashi Y., Okuno A., Nagasawa H., Nakajima T., Matsumoto T., Kato S. Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex. Mol. Cell. Biol. 22:2002;3698-3706.
14. Knutti D., Kaul A., Kralli A. A tissue-specific coactivator of steroid receptor, identified in a functional yeast screen. Mol. Cell. Biol. 20:2000;2411-2422.
15. Langley E., Zhou Z.X., Wilson E.M. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J. Biol. Chem. 270:1995;29983-29990.
16. -/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity. J. Biol. Chem. 273:1998;92-101.
17. Lim-Tio S.S., Keightley M.-C., Fuller P.J. Determinants of specificity of transactivation by the mineralocorticoid or glucocorticoid receptor. Endocrinology. 138:1997;2537-2543.
18. Liu W., Wang J., Yu G., Pearce D. Steroid receptor transcriptional synergy is potentiated by disruption of the DNA-binding domain dimer interface. Mol. Endocrinol. 10:1996;1399-1406.
19. Matias P.M., Donner P., Coelho R., Thomaz M., Peixoto C., Macedo S., Otto N., Joschko S., Scholz P., Wegg A., Bäsler S., Schäfer M., Ruff M., Egner U., Carrondo M.A. Structural evidence for ligand specificity in the binding domain of the human androgen receptor: implications for pathogenic gene mutations. J. Biol. Chem. 275:2000;26164-26171.
20. McInerney E.M., Tsai M.-J., O'Malley B.W., Katzenellenbogen B.S. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc. Natl. Acad. Sci. USA. 93:1996;10069-10073.
21. McPhaul M.J., Marcelli M., Tilley W.D., Griffin J.E., Isidro-Gutierrez R.F., Wilson J.D. Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J. Clin. Invest. 87:1991;1413-1421.
22. Métivier R., Penot G., Flouriot G., Pakdel F. Synergism between ERα transactivation function-1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 α-helical core and for a direct interaction between the N- and C-terminal domains. Mol. Endocrinol. 15:2001;1953-1970.
23. Nemoto T., Ohara-Nemoto Y., Sato N., Ota M. Dual role of 90-kDa heat shock protein in the function of the mineralocorticoid receptor. J. Biochem. 113:1993;769-775.
24. Rogerson F.M., Fuller P.J. Mineralocorticoid action. Steroids. 65:2000;61-73.
25. Rogerson F.M., Dimopoulos N., Sluka P., Chu S., Curtis A.J., Fuller P.J. Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor. J. Biol. Chem. 274:1999;36305-36311.
26. Rupprecht R., Arriza J.L., Spengler D., Reul J.M.H.M., Evans R.M., Holsboer F., Damm K. Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol. Endocrinol. 7:1993;597-603.
27. Sato A., Funder J.W. High glucose stimulates aldosterone-induced hypertrophy via type 1 mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology. 137:1996;4145-4153.
28. Savory J.G.A., Préfontaine G.G., Lamprecht C., Liao M., Walther R.F., Lefebvre Y.A., Haché R.J. Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces. Mol. Cell. Biol. 21:2001;781-793.
29. Tetel M.J., Giangrande P.H., Leonhardt S.A., McDonnell D.P., Edwards D.P. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol. Endocrinol. 13:1999;910-924.
30. Thompson J., Saatcioglu F., Jänne O.A., Palvimo J.J. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Mol. Endocrinol. 15:2001;923-935.
31. Zhou Z., Lane M.V., Kemppainen J.A., French F.S., Wilson E.M. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 9:1995;208-218.
32. Zoppi S., Wilson C.M., Harbison M.D., Griffin J.E., Wilson J.D., McPhaul M.J., Marcelli M. Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation. J. Clin. Invest. 91:1993;1105-1112.